Insider Trading & Ownership of Julia Aijun Wang

Location
Burlington, NC
Summary
The estimated net worth of Julia Aijun Wang is at least $90,213,336 dollars as of 13 Feb 2026. Julia Aijun Wang is the Chief Financial Officer of BeiGene, Ltd. and owns shares of BeOne Medicines Ltd. (ONC) stock worth about $88.61M. Julia Aijun Wang is the Chief Financial Officer, EVP of LABCORP HOLDINGS INC. and owns shares of LABCORP HOLDINGS INC. (LH) stock worth about $1.6M.
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Julia Aijun Wang
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Julia Aijun Wang and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Julia Aijun Wang has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $90,213,336.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BeiGene, Ltd. ($88,611,076).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Julia Aijun Wang

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONC, BEIGF BeiGene, Ltd. Chief Financial Officer $88,611,076 01 Jul 2024
LH LABCORP HOLDINGS INC. Chief Financial Officer, EVP $1,602,260 11 Feb 2026

Insider Transactions Reported by Julia Aijun Wang:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .